Assessment of Thyroid Fine-Needle Aspirates Using 2023 Bethesda System
Acta Cytologica · 2025
DOI: 10.1159/000544807 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Cytologica, 2025. Verfasst von Niti Sureka und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India. Hauptthemen laut MEDLINE: Thyroid Nodule, Thyroid Neoplasms, Thyroid Gland. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Introduction
Thyroid nodules are common, with about 5% being malignant, necessitating accurate evaluation to avoid unnecessary surgeries. Fine-needle aspiration cytology (FNAC) is a crucial diagnostic tool, and the 2023 Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) refines FNAC’s diagnostic accuracy and risk stratification for thyroid lesions. Materials and Methods: This retrospective study reclassified thyroid FNAs performed at a tertiary care centre from January 2023 to June 2024 using the 2023 TBSRTC and compared with available histopathological diagnoses. FNAC slides were reviewed and reclassified according to the 2023 TBSRTC categories by two cytopathologists. Statistical analysis included sensitivity, specificity, positive predictive value, negative predictive value, and overall diagnostic accuracy.
Results
The study included 387 patients (female-to-male ratio of 4:1), with 8% non-diagnostic, 61.5% benign, 9% AUS, 7.5% FN, 8% SFM, and 6% malignant cases. Histopathological correlation was available for 190 cases, revealing 126 benign and 64 malignant lesions. Considering NIFTP as benign on histopathology, the ROM for benign, FN, and SFM categories was 10%, 38%, and 69.2%, respectively. The highest sensitivity (88.2%) was achieved when AUS, FN, SFM, and malignant categories were considered positive for malignancy. The highest diagnostic accuracy (85.4%) was observed when SFM and malignant categories were considered positive.
Conclusion
FNAC, guided by the 2023 TBSRTC, is a reliable diagnostic tool for thyroid lesions, offering high sensitivity and specificity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.
Zitieren
APA
Sureka, N., Ahluwalia, C., Ahuja, S., Madan, N. K., Agrawal, M., & Ranga, S. (2025). Assessment of Thyroid Fine-Needle Aspirates Using 2023 Bethesda System. Acta Cytologica. https://doi.org/10.1159/000544807
Vancouver
Sureka N, Ahluwalia C, Ahuja S, Madan NK, Agrawal M, Ranga S. Assessment of Thyroid Fine-Needle Aspirates Using 2023 Bethesda System. Acta Cytologica. 2025. doi:10.1159/000544807
BibTeX
@article{Sureka2025,
author = {Sureka, Niti and Ahluwalia, Charanjeet and Ahuja, Sana and Madan, Neha Kawatra and Agrawal, Meetu and Ranga, Sunil},
title = {Assessment of Thyroid Fine-Needle Aspirates Using 2023 Bethesda System},
journal = {Acta Cytologica},
year = {2025},
doi = {10.1159/000544807}
}
EUVIMED